THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE.

DEFINITIVE CONTRACT won by ALBERT B. SABIN VACCINE INSTITUTE, INC. (THE) · work in WASHINGTON, DC
$98,624,151
RecipientALBERT B. SABIN VACCINE INSTITUTE, INC. (THE) UEI H5E8NU6N2HZ5
Award ID75A50119C00055
Award amount$98,624,151
Award typeDEFINITIVE CONTRACT
Awarding agencyDepartment of Health and Human Services — Office of Assistant Secretary for Preparedness and Response
NAICS541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSCAN73
Start dateSep 26, 2019
End dateAug 30, 2025
Place of performanceWASHINGTON, DC
Record updatedAug 17, 2022

View the official award record

Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.

Search open bids